These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 21651006)
1. Unraveling cancer risk with cellular and molecular tools. Patlak M Environ Sci Technol; 1998 Jul; 32(13):312A-6A. PubMed ID: 21651006 [TBL] [Abstract][Full Text] [Related]
3. Smoking and lung cancer: future research directions. Haussmann HJ Int J Toxicol; 2007; 26(4):353-64. PubMed ID: 17661227 [TBL] [Abstract][Full Text] [Related]
4. Reducing uncertainty in risk assessment by using specific knowledge to replace default options. McClellan RO Drug Metab Rev; 1996; 28(1-2):149-79. PubMed ID: 8744594 [TBL] [Abstract][Full Text] [Related]
5. On the incorporation of chemical-specific information in risk assessment. Clewell HJ; Andersen ME; Blaauboer BJ Toxicol Lett; 2008 Aug; 180(2):100-9. PubMed ID: 18588959 [TBL] [Abstract][Full Text] [Related]
6. New directions in incidence-dose modeling. Andersen ME; Dennison JE; Thomas RS; Conolly RB Trends Biotechnol; 2005 Mar; 23(3):122-7. PubMed ID: 15734554 [TBL] [Abstract][Full Text] [Related]
7. [Traditional and innovative diagnostic tools: when and why they should be applied]. Cancrini G; Iori A Parassitologia; 2004 Jun; 46(1-2):173-6. PubMed ID: 15305711 [TBL] [Abstract][Full Text] [Related]
8. The importance of clinical trials in unraveling the mysteries of multiple sclerosis. McFarland H J Neuroimmunol; 2011 Feb; 231(1-2):3-6. PubMed ID: 21300410 [TBL] [Abstract][Full Text] [Related]
9. Understanding mechanisms of toxicity: insights from drug discovery research. Houck KA; Kavlock RJ Toxicol Appl Pharmacol; 2008 Mar; 227(2):163-78. PubMed ID: 18063003 [TBL] [Abstract][Full Text] [Related]
10. Arsenic-induced carcinogenesis--oxidative stress as a possible mode of action and future research needs for more biologically based risk assessment. Kitchin KT; Conolly R Chem Res Toxicol; 2010 Feb; 23(2):327-35. PubMed ID: 20035570 [TBL] [Abstract][Full Text] [Related]
12. On the need for restricting the probabilistic analysis in risk assessments to variability. Aven T Risk Anal; 2010 Mar; 30(3):354-60; author reply 381-4. PubMed ID: 19919552 [TBL] [Abstract][Full Text] [Related]
13. Spatially explicit ecological exposure models: a rationale for and path toward their increased acceptance and use. Wickwire T; Johnson MS; Hope BK; Greenberg MS Integr Environ Assess Manag; 2011 Apr; 7(2):158-68. PubMed ID: 21442731 [TBL] [Abstract][Full Text] [Related]
14. Pharmaceuticals in the environment: lessons learned for reducing uncertainties in environmental risk assessment. Brooks BW; Berninger JP; Kristofco LA; Ramirez AJ; Stanley JK; Valenti TW Prog Mol Biol Transl Sci; 2012; 112():231-58. PubMed ID: 22974742 [TBL] [Abstract][Full Text] [Related]
15. Genetics of manic depressive illness: current status and evolving concepts. Baron M Res Publ Assoc Res Nerv Ment Dis; 1991; 69():153-64. PubMed ID: 2003158 [TBL] [Abstract][Full Text] [Related]
16. On different types of uncertainties in the context of the precautionary principle. Aven T Risk Anal; 2011 Oct; 31(10):1515-25. PubMed ID: 21477085 [TBL] [Abstract][Full Text] [Related]
18. The role of quantitative risk assessments for characterizing risk and uncertainty and delineating appropriate risk management options, with special emphasis on terrorism risk. Aven T; Renn O Risk Anal; 2009 Apr; 29(4):587-600. PubMed ID: 19144065 [TBL] [Abstract][Full Text] [Related]